Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Obese Children and Adolescents
NCT01487993Phase 3Completed
- Start
- Aug 2011
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in obesity, insulin resistance (IR). Started Aug 2011; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
obesityinsulin resistance (IR)
Beyond the preview
Go deeper on NCT01487993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01487993.